๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

10 recruiting trials

for Early Breast Cancer (EBC)

NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III) NCT06081244Phase 343 sites๐Ÿ“ Baden-Baden๐Ÿ“ Bรถblingen๐Ÿ“ Freiburg im Breisgau Women's Cancer Study Group GmbH ยท Tests: Sacituzumab govitecan, Pembrolizumab Tirzepatide Weight Loss for MRD+ Early Breast Cancer NCT06517212Phase 21 site๐Ÿ“ Dallas Baylor Research Institute ยท Tests: Tirzepatide neoAGORA: Exploring Clinical Utility of Serial Liquid Biopsy (ctDNA) in Patients With Early-Stage Breast Cancer NCT07718841n/a10 sites๐Ÿ“ San Sebastiรกn๐Ÿ“ Barcelona๐Ÿ“ Madrid Spanish Breast Cancer Research Group ยท Tests: biological samples, images, and clinical data Impact of "Targeted" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT) NCT06928701NA1 site๐Ÿ“ Novara University of Eastern Piedmont ยท Tests: omega-3 (n-3 Lc-PUFA), EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) plus a source of palmitoleic acid (heโ€ฆ Impact of Exercise on Quality of Life of EBC Patients on Treatment With Adjuvant AI With or Without CDK4/6 Inhibitors NCT07215364NA5 sites๐Ÿ“ L'Hospitalet de Llobregat๐Ÿ“ Pamplona๐Ÿ“ Granada Spanish Breast Cancer Research Group ยท Tests: Training program PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS NCT05792150n/a71 sites๐Ÿ“ Baden-Baden๐Ÿ“ Pforzheim๐Ÿ“ Stuttgart Women's Cancer Study Group GmbH ctDNA in HER2+ EBC Neoadjuvant Treatment NCT07335081Phase 21 site๐Ÿ“ Shanghai Shanghai Jiao Tong University School of Medicine ยท Tests: pyrotinib, pertuzumab, trastuzumab, docetaxel Neoadjuvant Pyrotinib-to-pertuzumab in HER2+ eBC NCT07797218Phase 31 site๐Ÿ“ Shanghai Shanghai Jiao Tong University School of Medicine ยท Tests: Docetaxel, Pyrotinib, Trastuzumab (Herceptin), Pertuzumab Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- eBC NCT07242352Phase 333 sites๐Ÿ“ Mannheim๐Ÿ“ Tรผbingen๐Ÿ“ Esslingen am Neckar Women's Cancer Study Group GmbH ยท Tests: Elacestrant, Standard-of-care endocrine treatment Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer ๏ผˆEBC๏ผ‰ NCT06107673Phase 21 site๐Ÿ“ Shijiazhuang Hebei Medical University Fourth Hospital ยท Tests: Dalpiciclib, Aromatase inhibitor, Docetaxel injection, Epirubicin Hydrochloride Injection, Cyclophosphamide injection
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy